Interview with Ulf Schneider, Managing Partner, RUSSIA CONSULTING
You founded this business in 2003, and it has since grown to encompass five offices and over 250 experts. Can you tell our readers a bit about the history behind…
Address: Ul. Bakhrushina 32/1, 115054, Moscow ,Russia
Tel: +7 495 956 55 57
Web: http://Russia-consulting.eu/
Russia CONSULTING supports Western companies in business set-up and expansion in Russia, Belarus, Kazakhstan and Ukraine, where we have offices in Moscow and St. Petersburg, Minsk, Almaty, and Kiev, employing 260 staff. All our offices and projects are led by a Western professionally qualified partner/director with significant experience of working in this region.
We assist initial market entry by providing a registered office address, fully equipped office accommodation and related support services, including the nominating of an experienced and trustworthy Russian/local national employee to act as interim General Director, should these services be needed.
Our main activity is in performing the outsourced accounting function under Russian accounting rules and in generating from this the management reports required by the foreign owner or auditor, including their transformation to US GAAP or IFRS.
We also provide
• accounting and tax compliance services required by local legislation,• non complex legal services (work permit, visa support, contract advice between parent and daughter and in relation to personnel matters, shareholder resolutions, advice on capital increase),• recruiting/assessment of experienced finance/accounting staff,• IT consultancy on “1 C” software (the predominant Russian accounting software) and Navision, including their interface with SAP.• Formal take-over of General Director function according to local statutory legislation.
Through our associate CHECKPOINT Russia we are able to assist companies with operational and logistical issues, such as market and industry analyses and import and export.
Our services will be particularly useful to companies setting up or developing a subsidiary, representative office or branch in Russia/CIS, as through our experience and focus on this activity we are able to anticipate your needs and resolve any issues that may arise.
We aim not to compete with but to work alongside and closely co-operate with your US auditors and legal advisers.
Market entry, finance, accounting, and office management services.
You founded this business in 2003, and it has since grown to encompass five offices and over 250 experts. Can you tell our readers a bit about the history behind…
You founded this business in 2003, and it has since grown to encompass five offices and over 250 experts. Can you tell our readers a bit about the history behind…
The following is an interview with Dr. Smirnov, as well as Dr. Dmitri Pavlovich, Director, Clinical Operations Russia Quintiles very recently announced the launch of its first commercial project in…
The following is an interview with Dr. Pavlovich, as well as Dr. Sergey Smirnov, Director, Business Development and Operations, CEE, CIS and Russia Quintiles very recently announced the launch of…
The following is joint interview of Mr. Vayntrub and Regina Karymova, General Manager of Invar Mr. Vayntrub, you founded Invar in 1991, and began to capitalize on foreign investment in…
Pepeliaev, Goltsblat & Partners and the major UK firm Berwin Leighton Paisner (BLP). It calls itself the first international Russian law firm. Can you explain to our readers the rationale…
You have lead this company since its beginnings in 2003, when it acquired ICN pharmaceuticals. In 2007, Pharmstandard carried out an IPO of 43% of its shares. How has the…
You were working for GSK since 2003 before joining Galderma this year. Some within the industry might view Galderma as a step down from the third-ranked pharmaceutical company in the…
GSK CEO Andrew Witty has said that GSK must move away from selling “white pills in Western markets” in order to offset widespread generic erosion. This means diversifying the company’s…
Janssen recently signed memorandums of understanding with both the Skolkovo Foundation and ChemRar. Can you describe the strategic parameters and intended outcomes of these agreements? How do they factor into…
Mr. Demidov, you are one of the pioneers of market research studies in Russia. There is a quote you like to use: ‘Market research is a business in the United…
How would you describe CMS’s own presence in the life sciences field in Russia, and what unique competitive advantages does the firm bring to this area of practice? Over the…
With the announcement of the Pharma 2020 strategy to develop the domestic pharmaceutical industry, multinational companies have pledged an excess of $1Bn in investment into local infrastructure. Servier, however, preempted…
See our Cookie Privacy Policy Here
